Curriculum Vitae and Bibliography Kenneth R Olivier, MD · Curriculum Vitae and Bibliography Present Academic Rank and Position Consultant - Department of Radiation Oncology, Mayo

Kenneth R Olivier, MDCurriculum Vitae and Bibliography

Present Academic Rank and PositionConsultant - Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota

08/2011 - Present

Vice Chair for Education - Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota

04/2013 - Present

Residency Program Director - Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota

07/2013 - Present

Professor of Radiation Oncology - Mayo Clinic College of Medicine and Science 04/2017 - Present

CertificationBoard Certifications

American Board of Radiology (ABR)

Radiation Oncology 2002 - Present

Mayo Clinic Quality Academy

Mayo Clinic Quality Fellow: Bronze Level Certification 2011

Additional Education

Clinical Interventional OncologyPanel member for case presentations in Liver and Lung tumorsMiami, Florida

01/2015 - 02/2015

EducationHope College - BA, Business Administration and Psychology 1988 - 1990

Wayne State University School of Medicine - MD 1993 - 1997

Butterworth Hospital - Internship 1997 - 1998

Mayo Graduate School of Medicine, Mayo Clinic College of Medicine - Resident, Radiation Oncology

1998 - 2002

Personal InformationPlace of Birth: Grand Rapids, MI

Citizenship: United States of America

Work Address: Mayo Clinic Rochester200 First St SWRochester, MN 55905-0001

Email Address: [email protected]

RE-AIMS 09/15/2017

LicensureFlorida ME95432 (Medical) 03/2006 - PresentWisconsin 52327 (Medical) 10/2008 - 2015Minnesota 41035 (Medical) 11/2008 - Present

Previous Professional Positions and Major AppointmentsAssociate Consultant - Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota

09/2002 - 03/2004

Instructor in Oncology - Mayo Clinic College of Medicine and Science 01/2003 - 03/2004

Assistant Professor in Radiation Oncology - University of Florida, Gainesville, Florida

2004 - 2008

Assistant Professor - University of Florida, Gainesville, FloridaAssistant Professor of Radiation Oncology at the University of Florida in Gainesville.

07/2004 - 08/2008

Senior Associate Consultant - Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota

08/2008 - 08/2011

Assistant Professor in Radiation Oncology - Mayo Clinic College of Medicine and Science

04/2010 - 08/2011

Associate Professor in Radiation Oncology - Mayo Clinic College of Medicine and Science

09/2011 - 03/2017

Professional Memberships and Services

Aesculapians

Professional and Community Memberships, Societies, and Services

Honors and Awards

Cum Laude - Hope College - Present

Honors for Year III of medical school - Wayne State University 01/1995 - 01/1996

Student Representative to AAMC - Wayne State University 01/1995 - 01/1997

Penfield Award - Wayne State University 01/1997

Top 20% of graduating class - Wayne State University 01/1997

Moreton Fellow - Mayo Graduate School of Medicine, Mayo Clinic College of Medicine

01/2001 - 01/2002

K-12 , Davenport fellow - Mayo Graduate School of Medicine, Mayo Clinic College of Medicine

01/2002 - 01/2003

Resident Research Award - Radiological Society of North America 01/2002

Teacher of the year in Radiation Oncology - University of Florida 01/2006

Excellence in Teaching - University of Florida 01/2007

Teacher of the Year - Mayo Fellows Association, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine, Rochester, Minnesota

2010

RE-AIMS 09/15/2017

Kenneth R Olivier, MD Page 2 of 23

MemberAid to Impaired Medical Students

Student Member 08/1996 - 06/1997American Board of Radiology

Volunteer 03/2007 - PresentAmerican College of Radiology

Site Representative 07/2014 - PresentAssociation of American Medical Colleges

Student Representative 01/1995 - 01/1997Chaplain's Executive Committee

Member 08/1990 - 12/1990National Institutes of Health

Radiation Therapy Oncology GroupRTOG Steering Committee for Lung Cancer

Member 01/2003 - 06/2013University of Florida

Clinic Improvement CommitteeMember 01/2007 - Present

Healthcare Safety CommitteeMember 01/2008

Protocol Review and Resource UtilizationMember 01/2007 - Present

Radiation Oncology Chair searchMember 01/2007 - Present

UpToDateEditor of Website 05/2015 - Present

Journal Editorial Responsibilities

Frontiers in Radiation OncologyAssociate Editor 01/2011 - Present

Journal Other Responsibilities

American Journal of Clinical Oncology

Reviewer

Cancer

Reviewer

Chest

Reviewer

Head and Neck

Community Memberships and Services

Committee for Accreditation of Medical Physics Education ProgrampsReviewer 01/2006 - Present

Journal Responsibilities

RE-AIMS 09/15/2017


Reviewer

International Journal of Radiation Oncology Biology and Physics

Reviewer

Journal of Thoracic Oncology

Reviewer 06/2010 - Present

Practical Radiation Oncology

Reviewer 08/2013 - Present

Radiation Therapy and Oncology

Reviewer

Curriculum and Course Development

Professional Mentoring for Radiation OncologyMonthly lectures to the residents in Radiation Oncology given over a 2 year period. Topics are related to professional development in Radiation Oncology

Radiobiology reviewReviewed Radiobiology with residents in Radiation OncologyUniversity of FloridaGainesville, Florida

04/2004 - 07/2008

Mayo Clinic Radiation Oncology: Current Practice and Future DirectionsProgram Co-Director for first SAM course for department

Hawaii

01/2016 - 01/2016

Educational Activities

RE-AIMS 09/15/2017


Teaching Intramural

Stereotactic Body Radiotherapy for Non-Small Cell Lung CancerMayo Clinic

CNS malignanciesSchool of Radiotherapy at Mayo ClinicRochester, Minnesota

2000 - 2001

Radiation Oncology Basicsto Medical OncologyUniversity of FloridaGainesville, Florida

2004 - 2008

Radiation for Lung Cancerto Pulmonary MedUniversity of FloridaGainesville, Florida

2004 - 2008

The Lymphomasto UF MSIIUniversity of FloridaGainesville, Florida

2004 - 2008

Lung Cancerto UF MSIIUniversity of FloridaGainesville, Florida

2004 - 2008

Radiobiologyto Radiation Oncology residentsUniversity of FloridaGainesville, Florida

2005 - 2008

Myeloma and PlasmacytomasOncology Core CurriculumMayo Clinic Core CurriculumRochester, Minnesota

2008

Lung SBRTMayo Clinic Core Curriculum

2012

Mentorship

Chera, Bisham (Radiation Oncology Resident)Description: Current Status: Outcome:

01/2004

Chopra, Rahul (Medical Student)Description: Current Status: Outcome:

01/2004

RE-AIMS 09/15/2017


Chang, Daniel (Radiation Oncology Resident)Description: Current Status: Outcome:

01/2004 - 01/2006

Walsh, Kathy (Internal Medicine Resident)Description: Current Status: Outcome:

01/2005 - Present

Byer, Gracie (Undergraduate Student)Description: Current Status: Outcome:

01/2006

Newlin, Heather (Radiation Oncology Resident)Description: Current Status: Outcome:

01/2007

Saito, Aneyuko (Visiting Faculty)Description: Current Status: Outcome:

01/2007

Shi, Wenyin (Radiation Oncology Resident)Description: Current Status: Outcome:

01/2007

Yueng, Anamaria (Radiation Oncology Resident)Description: Current Status: Outcome:

01/2007

Hallemeier, Christopher (Radiation Oncology Resident)Description: Current Status: Outcome:

01/2009 - Present

Wilson, Zachary (Radiation Oncology Resident)Description: Current Status: Outcome:

01/2010 - 01/2014

Park, Sean (Assistant Professor)Description: Current Status: Assistant professorOutcome:

01/2012 - Present

RE-AIMS 09/15/2017


Presentations ExtramuralNational or International

Invited

Radiation Therapy for Parotid Lymphoma 04/2002American Radium Society

Introduction to Gene Therapy 07/2002American Associtation of Physicists in MedicineMontreal, Quebec, Canada

Introduction to Radiation Oncology 12/03/2004ASCO Multidisciplinary Cancer Management Course

The Lymphomas 03/25/2006

Institutional/Departmental Administrative Responsibilities, Committee Memberships, and Other Activities

Mayo Clinic in Rochester

Assistant Residency Directory

Assistant Residency Director 2010 - 05/15/2013

Department of Radiation Oncology

Regional Practice Committee

Member 2008 - 05/01/2013

Saftey Initiative Group-Radiation Oncology

Member 01/2011 - 06/08/2017

Mayo Clinic in Arizona

Mayo Clinic in Arizona

Department of Education Services

Graduate Medical Education

Active Member 05/2013 - Present

Activities at Other Institutions

Oncology Review Committee

Reviewer - protocol 02/2011 - 05/2013

Academic Career Development

Whitney MacMillan Physician Leadership Business AcademyA business and leadership development series arranged by Mayo to develop future leaders in the institution.Whitney MacMillan Physician Leadership Business AcademyMayo Clinic; Rochester, Minnesota

04/2016 - 09/2016

RE-AIMS 09/15/2017


ASTRO Review CourseMiami, Florida

IGRT at the University of Floirda 10/13/2006Korean Society of RAdiotherapy and OncologySeoul, South Korea

Lung IGRT at the University of Florida 04/21/2007ASTRO IGRT Symposium

Stereotactic Body Radiotherapy for Spin and Lung Tumors 07/27/2007Japanese Society for Stereotactic RadiotherapyTokyo, Japan

Comparison of Prescription Methods for Stereotactic Body Radiotherapy in Lung Cancer

10/31/2007

ASTRO

Stereotactic Body Radiotherapy at the University of Florida 01/16/2008The Medical CityManila, Philippines

Advanced Stage Lung Cancers 11/03/2010American Society of Theraputic Radiation OncologySan Diego, California

Stereotactic Body Radiotherapy-The Mayo Experience 11/23/2010Spectrum Health Department of Radiation OncologyGrand Rapids, Michigan

Radiotherapy for Melanoma 02/18/2011University of Otago Inaugural International Cancer SymposiumWellington, New Zealand

Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer 02/18/2011University of Otago Inaugural International Cancer SymposiumWellington, New Zealand

Spine SBRT 03/28/2011Mayo Spine SymposiumNaples, Florida

SBRT for Liver Metastases 11/28/2012RSNA National MeetingChicago, Illinois

SBRT for Soft Tissue and Bone Metastases 12/2013RSNAChicago, Illinois

RE-AIMS 09/15/2017


SBRT for Bone Metastases 05/12/2014World Congress on Interventional OncologyNew York City, New York

SBRT for focal bone metastases 05/12/2014World Conference on Interventional OncologyNew York, New York

SBRT for pulmonary nodules: trial updates 12/2014RSNAChicago, Illinois

Lung SBRT 02/01/2015Conference on Interventional Oncology (CIO)Miami, Florida

Role for SBRT in the Treatment of Primary Lung Tumors 12/01/2015Radiological Society of North America (RSNA) Assemply and Annual MeetingChicago, Illinois

Locally Advanced Lung Cancer-Discussant 09/28/2016Reviewed and put in context oral presentations at the yearly Radiation Oncology meeting, ASTROASTROBoston, Massachusetts

SBRT for pulmonary nodules 11/29/2016RSNAChicago, Illinois

Oral

Radiation Therapy for Parotid Lymphoma 04/2002Oral PresentationAmerican Radium Society

Introduction to Gene therapy 07/2002American Association of Physicists in Medicine

Process for using Proton Therapy in Spine SBRT 06/10/2015International Stereotactic Radiosurgery Society (ISRS) CongressYokohama, Japan

Poster

Fractionated Radiation Alone Protects C57BL Mice from Challenge with CMT Cells if Challenged within 28 Days from the Completion of Radiation

06/2003

American Society of Gene Therapy

RE-AIMS 09/15/2017


Fusing Tumor Cell Vaccines Are Potent Immunogens At Least In Part Through The Release of Exosome-like Vesicles Which Load Dendritic Cells With Tumor Antigen

06/2003

American Society of Gene Therapy

Regional

Invited

Radiation and Gene Therapy 05/2001Minnesota Radiologic SocietyMinneapolis, Minnesota

SBRT for Early Lung Cancers 02/200636th Annual University of Florida Radiation Oncology Outcomes Tracking Seminar

Treatment of Early Stage Lung Cancer 09/15/2006Joint Cancer ConferencePalm Beach, Florida

SBRT for Early Lung CAncer at the University of Florida 11/04/2006Florida Society of Clinical OncologyMiami, Florida

Image Guided Radiotherapy 02/23/2007University of Florida Radiation Therapists Convention

Radiotherapy for Metastatic Melanoma 02/23/200737th Annual University of Florida Radiation Oncology Outcomes Tracking Seminar

Different Prescription Methods in Lung SBRT 02/200838th Annual University of Florida Radiation Oncology Outcomes Tracking Seminar

Radioimmunotherapy 02/2008University of Florida Radiation Therapists Convention

Oral

Radiation and Gene Therapy 05/2001Minnesota Radiologic Society

Visiting ProfessorshipVisiting Professorships

Introduction and History of SBRTMayo Clinic Jacksonville

03/28/2011

Visiting Professor In Radiation OncologyMayo Clinic Jacksonville, Department of Radiation Oncology

03/28/2011 - 03/30/2011

RE-AIMS 09/15/2017


SBRT for Spine and Liver tumorsMayo Clinic Jacksonville

03/29/2011

SBRT for Lung tumorsMayo Clinic Jacksonville

03/30/2011

Visiting ProfessorUniversity of FloridaGainesville, Florida

09/26/2011

Clinical Practice, Interests, and AccomplishmentsStereotactic Body Radiotherapy for primary cancers and aggressive treatment of metastatic disease Lung Cancers.

Research InterestsStereotactic Body Radiotherapy: Co-PI on RTOG 0915 looking at 2 different doses of SBRT for NSCLC. SBRT as immunostimulant in Melanoma Clinical Outcomes of SBRT for all sites Lung Cancer: Clinical treatment and outcomes for Lung CA Funded Research: William Beaumont Hospital, Royal Oak, MI. Research externship. $1500. 1994. Mayo Clinic, Rochester, MN. K12 training grant. $75,000 a year. 2002-2004. University of Florida, Gainesville, FL. MRI motion study in lung cancer (co-PI). State of Florida DOH. $95,000 over 2 years. 2005-2007. University of Florida, Gainesville, FL. External Beam Radiotherapy and Bexxar (PI). Glaxo-Smith-Kline PI initiated protocol. $15,000 in 2007. 2007-current.

Active Grants

Federal

Co-Investigator A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR. Funded by National Cancer Institute. (R01 CA 200551)

02/2016 - 01/2019

Industry

Program Director / Principal Investigator

A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC): Amendment #1-Internal A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC). Funded by Varian Oncology Systems

12/2015 - 11/2022

Research Grants Awarded

RE-AIMS 09/15/2017


Bibliography

Peer-reviewed Articles

1. Crittenden MR, Gough MJ, Harrington K, Olivier KR, Thompson J, Vile RG. Expression of Inflammatory Cytokines Combines with Local Tumor Destruction Enhances Tumor Regression and Long-term Immunity. Cancer Research. 2002; 63:5505-5512.

2. Kruse JJ, Herman MG, Hagness CR, Davis BJ, Garces YI, Haddock MG, Olivier KR, Stafford SL, Pisansky TM. Electronic and film portal images: A comparison of landmark visibility and review accuracy. Int J Radiat Oncol Biol Phys. 2002 Oct 1; 54(2):584-91. PMID:12243839

3. Linardakis E, Bateman A, Phan V, Ahmed A, Gough M, Olivier K, Kennedy R, Errington F, Harrington KJ, Melcher A, Vile R. Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion. Cancer Res. 2002 Oct 1; 62(19):5495-504. PMID:12359759

4. Mora GR, Olivier KR, Cheville JC, Mitchell RF Jr, Lingle WL, Tindall DJ. The cytoskeleton differentially localizes the early growth response gene-1 protein in cancer and benign cells of the prostate. Mol Cancer Res. 2004 Feb; 2(2):115-28. PMID:14985468

5. Olivier KR, Brown PD, Stafford SL, Ansell SM, Martenson JA. Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin lymphoma of the parotid gland. Int J Radiat Oncol Biol Phys. 2004 Dec 1; 60(5):1510-4. PMID:15590182 DOI:10.1016/j.ijrobp.2004.05.066

6. Mora GR, Olivier KR, Mitchell RF, Jenkins RB, Tindall DJ. Regulation of expression of the early growth response gene-1 (EGR-1) in malignant and benign cells of the prostate. Prostate. 2005 May 1; 63(2):198-207. PMID:15486985 DOI:10.1002/pros.20153

7. * Chang DT, Zlotecki RA, Olivier KR. Re-examining the role of elective nodal irradiation: finding ways to maximize the therapeutic ratio. Am J Clin Oncol. 2005 Dec; 28(6):597-602. PMID:16317271

8. Mendenhall WM, Olivier KR, Lynch JW Jr, Mendenhall NP. Lethal midline granuloma-nasal natural killer/T-cell lymphoma. Am J Clin Oncol. 2006 Apr; 29(2):202-6. PMID:16601443 DOI:10.1097/01.coc.0000198738.61238.eb

9. * Chang DT, Olivier KR, Morris CG, Liu C, Dempsey JF, Benda RK, Palta JR. The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2006 May 1; 65(1):125-31. Epub 2006 Jan 19. PMID:16427214 DOI:10.1016/j.ijrobp.2005.09.047

10. * Chopra R, Mendenhall WM, Morris CG, Zlotecki RA, Olivier KR. Surgery and postoperative radiotherapy for adenoid cystic carcinoma of the lung. Am J Clin Oncol. 2006 Aug; 29(4):420-1. PMID:16891874 DOI:10.1097/01.coc.0000171280.16889.d0

11. Liauw SL, Yeh AM, Morris CG, Olivier KR, Mendenhall NP. Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation. Int J Radiat Oncol Biol Phys. 2006 Dec 1; 66(5):1440-5. Epub 2006 Sep 25. PMID:16997504 DOI:10.1016/j.ijrobp.2006.07.014

12. * Chang D, Liu C, Dempsey JF, Palta JR, Kopea J, Louis D, Morris C, Chopra R, Olivier KR. Predicting changes in dose distribution to tumor and normal tissue when correcting for heterogeneity in radiotherapy for lung cancer. Am J Clin Oncol. 2007 Feb; 30(1):57-62. PMID:17278896 DOI:10.1097/01.coc.0000251222.36417.3b

RE-AIMS 09/15/2017


13. Olivier KR, Schild SE, Morris CG, Brown PD, Markovic SN. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma. Cancer. 2007 Oct 15; 110(8):1791-5. PMID:17721993 DOI:10.1002/cncr.22988

14. Vargas C, Mahajan C, Fryer A, Indelicato D, Henderson RH, McKenzie C, Horne D, Chellini A, Lawlor P, Li Z, Oliver K, Keole S. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1110-6. PMID:17967305 DOI:10.1016/j.ijrobp.2007.04.075

15. * Chera BS, Olivier K, Morris CG, Lynch JW, Mendenhall NP. Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida. Am J Clin Oncol. 2007 Dec; 30(6):601-6. PMID:18091054 DOI:10.1097/COC.0b013e318145b9db

16. Vargas C, Fryer A, Mahajan C, Indelicato D, Horne D, Chellini A, McKenzie C, Lawlor P, Henderson R, Li Z, Lin L, Olivier K, Keole S. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Mar 1; 70(3):744-51. Epub 2007 Sep 27. PMID:17904306 DOI:10.1016/j.ijrobp.2007.07.2335

17. * Yeung AR, Vargas CE, Falchook A, Louis D, Olivier K, Keole S, Yeung D, Mendenhall NP, Li Z. Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate cancer therapy. Int J Radiat Oncol Biol Phys. 2008 Dec 1; 72(5):1426-33. Epub 2008 Aug 30. PMID:18762391 DOI:10.1016/j.ijrobp.2008.03.031

18. Saito AI, Li JG, Liu C, Olivier KR, Dempsey JF. Accurate heterogeneous dose calculation for lung cancer patients without high-resolution CT densities. J Appl Clin Med Phys. 2009; 10(2):2847. Epub 2009 Apr 30. PMID:19458588

19. * Chang D, Pacholke H, Amdur R, Mendenhall N, Morris C, Byer G, Olivier KR. Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: A potential role for parotid-sparing techniques? American Journal of Clinical Oncology. 2009.

20. Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR, Melanoma Study. Metastatic malignant melanoma. G Ital Dermatol Venereol. 2009 Feb; 144(1):1-26. PMID:19218908

21. Vargas C, Falchook A, Indelicato D, Yeung A, Henderson R, Olivier K, Keole S, Williams C, Li Z, Palta J. Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold. Am J Clin Oncol. 2009 Apr; 32(2):180-6. PMID:19307953 DOI:10.1097/COC.0b013e3181841f13

22. * Chang DT, Mendenhall NP, Lynch JW, Morris CG, Olivier KR. Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring. Am J Clin Oncol. 2009 Jun; 32(3):233-7. PMID:19433961 DOI:10.1097/COC.0b013e318187ddbb

23. * Newlin HE, Iyengar M, Morris CG, Olivier K. Unresectable squamous cell carcinoma of the lung: an outcomes study. Int J Radiat Oncol Biol Phys. 2009 Jun 1; 74(2):370-6. Epub 2009 Apr 06. PMID:19356860 DOI:10.1016/j.ijrobp.2008.08.019

24. Amdur RJ, Bennett J, Olivier K, Wallace A, Morris CG, Liu C, Mendenhall WM. A Prospective, Phase II Study Demonstrating the Potential Value and Limitation of Radiosurgery for Spine Metastases. Am J Clin Oncol. 2009 Jun 12. [Epub ahead of print] PMID:19528790 DOI:10.1097/COC.0b013e318194f70f

25. * Yeung AR, Li JG, Shi W, Newlin HE, Chvetsov A, Liu C, Palta JR, Olivier K. Tumor localization using cone-beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. Int J Radiat Oncol Biol Phys. 2009 Jul 15; 74(4):1100-7. Epub 2009 Apr 22. PMID:19395197 DOI:10.1016/j.ijrobp.2008.09.048

RE-AIMS 09/15/2017


26. Vargas C, Saito AI, Hsi WC, Indelicato D, Falchook A, Zengm Q, Oliver K, Keole S, Dempsey J. Cine-magnetic resonance imaging assessment of intrafraction motion for prostate cancer patients supine or prone with and without a rectal balloon. Am J Clin Oncol. 2010 Feb; 33(1):11-6. PMID:19730351 DOI:10.1097/COC.0b013e31819fdf7c

27. * Shi W, Liu C, Lu B, Yeung A, Newlin HE, Amdur RJ, Olivier KR. The effect of intravenous contrast on photon radiation therapy dose calculations for lung cancer. Am J Clin Oncol. 2010 Apr; 33(2):153-6. PMID:19806038 DOI:10.1097/COC.0b013e3181a44637

28. * Yeung AR, Li J, Shi W, Newlin H, Morris CG, Samant S, Saito A, Chvetsov A, Liu C, Palta J, Olivier K. Optimal image-guidance scenario with cone-beam computed tomography in conventionally fractionated radiotherapy for lung tumors. Am J Clin Oncol. 2010 Jun; 33(3):276-80. PMID:19841573 DOI:10.1097/COC.0b013e3181aaca41

29. * Shi W, Li JG, Zlotecki RA, Yeung A, Newlin H, Palta J, Liu C, Chvetsov AV, Olivier K. Evaluation of kV cone-beam ct performance for prostate IGRT: a comparison of automatic grey-value alignment to implanted fiducial-marker alignment. Am J Clin Oncol. 2011 Feb; 34(1):16-21. PMID:21189455 DOI:10.1097/COC.0b013e3181d26b1a

30. Stauder MC, Macdonald OK, Olivier KR, Call JA, Lafata K, Mayo CS, Miller RC, Brown PD, Bauer HJ, Garces YI. Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother Oncol. 2011 May; 99: (2)166-71. PMID:21571384 DOI:10.1016/j.radonc.2011.04.002

31. Schild SE, Foster NR, Meyers JP, Olivier KR, Ross HJ, Molina JR, Stella PJ, Past LR, Garces YI, Adjei AA, North Central Cancer Treatment Group. Prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC): Findings from a North Central Cancer Treatment Group (NCCTG) pooled analysis. J Clin Oncol. 2011 May 20; 29: (15_suppl)7074. PMID:28020366

32. * Barney BM, Olivier KR, Miller RC, Haddock MG. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma. Radiat Oncol. 2012; 7:67. Epub 2012 May 03. PMID:22553982 PMCID:3464963 DOI:10.1186/1748-717X-7-67

33. * Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR. Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Front Oncol. 2012; 2:215. Epub 2013 Jan 22. PMID:23346551 PMCID:3551203 DOI:10.3389/fonc.2012.00215

34. Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. The clinical case for proton beam therapy. Radiat Oncol. 2012; 7:174. Epub 2012 Oct 22. PMID:23083010 PMCID:3549771 DOI:10.1186/1748-717X-7-174

35. * Smith K, Byer G, Morris CG, Kirwan JM, Lightsey J, Mendenhall NP, Hoppe BS, Lynch J, Olivier K. Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Mar 1; 82(3):1122-7. Epub 2011 May 11. PMID:21570217 DOI:10.1016/j.ijrobp.2010.09.044

36. Saito AI, Li JG, Liu C, Olivier KR, Kyougoku S, Dempsey JF. Intravenous contrast agent influence on thoracic computed tomography simulation investigated through a heterogeneous dose calculation method using 5-bulk densities. Am J Clin Oncol. 2012 Apr; 35(2):110-4. PMID:21383608 DOI:10.1097/COC.0b013e318209a910

37. * Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Rose PS, Olivier KR, Brown PD, Brinkmann DH, Laack NN. Stereotactic body radiation therapy in spinal metastases. Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82(5):e803-9. Epub 2012 Feb 11. PMID:22330988 DOI:10.1016/j.ijrobp.2011.11.036

RE-AIMS 09/15/2017


38. Schild SE, Foster NR, Meyers JP, Ross HJ, Stella PJ, Garces YI, Olivier KR, Molina JR, Past LR, Adjei AA, North Central Cancer Treatment Group. Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis. Ann Oncol. 2012 Nov; 23: (11)2919-24. PMID:22782333 PMCID:3577038 DOI:10.1093/annonc/mds123

39. Barney BM, Olivier KR, Macdonald OK, Fong de, Miller RC, Haddock MG. Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors. Am J Clin Oncol. 2012 Dec; 35(6):537-42. PMID:21659830 DOI:10.1097/COC.0b013e31821f876a

40. Mayo CS, Zankowski C, Herman M, Miller R, Olivier K, Vincent A, Suominen J. A method to vectorize the dose distribution, the dose volume histogram and create a dose vector histogram. Med Phys. 2013 Jan; 40: (1)011717. PMID:23298087 DOI:10.1118/1.4769111

41. * Hallemeier CL, Stauder MC, Miller RC, Garces YI, Foote RL, Sarkaria JN, Bauer HJ, Mayo CS, Olivier KR. Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomes. Journal of Radiosurgery and SBRT.2013;2:(3):225-233.

42. * G Peacock J, A Call J, R Olivier K. Radiotherapy for metastatic fibrolamellar hepatocellular carcinoma. Rare Tumors. 2013; 5: (3)e28. PMID:24179640 PMCID:3804803 DOI:10.4081/rt.2013.e28

43. * Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR. Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Frontiers in Oncology. 2013; 2 JAN:215.

44. Hallemeier CL, Garces YI, Neben-Wittich MA, Olivier KR, Shon W, Garcia JJ, Brown PD, Foote RL. Adjuvant hypofractionated intensity modulated radiation therapy after resection of regional lymph node metastases in patients with cutaneous malignant melanoma of the head and neck. Pract Radiat Oncol. 2013 Apr-Jun; 3: (2)e71-7. PMID:24674323 DOI:10.1016/j.prro.2012.06.003

45. Seder CW, Allen MS, Cassivi SD, Deschamps C, Nichols FC, Olivier KR, Shen KR, Wigle DA. Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens. Ann Thorac Surg. 2013 May; 95(5):1708-16. Epub 2013 Mar 29. PMID:23545194 DOI:10.1016/j.athoracsur.2013.02.041

46. Grams M, de Los Santos LF, Brown L, Olivier K, Brinkmann D. TH-C-137-04: Separating the Dosimetric Consequences of Changing Tumor Anatomy Vs. Positional Uncertainty for Conventionally Fractionated Lung Cancer Patients. Med Phys. 2013 Jun; 40: (6Part32)533. PMID:28517875 DOI:10.1118/1.4815747

47. * Stauder MC, Rooney JW, Neben-Wittich MA, Garces YI, Olivier KR. Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy. Radiat Oncol. 2013 Jul 06; 8: ()167. PMID:23829565 PMCID:3707780 DOI:10.1186/1748-717X-8-167

48. * Barney BM, Markovic SN, Laack NN, Miller RC, Sarkaria JN, Macdonald OK, Bauer HJ, Olivier KR. Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT). Int J Radiat Oncol Biol Phys. 2013 Sep 01; 87: (1)73-80. PMID:23920388 DOI:10.1016/j.ijrobp.2013.05.012

49. * Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, Haddock MG, Foote RL, Olivier KR. Stereotactic body radiotherapy in the treatment of adrenal metastases. Am J Clin Oncol. 2013 Oct; 36(5):509-13. PMID:22781389 DOI:10.1097/COC.0b013e3182569189

50. Grams MP, Brown LC, Brinkmann DH, Pafundi DH, Mundy DW, Garces YI, Park SS, Olivier KR, de los Santos LE. Analysis of automatic match results for cone-beam computed tomography localization of conventionally fractionated lung tumors. Pract Radiat Oncol. 2014 Jan-Feb; 4: (1)35-42. PMID:24621421 DOI:10.1016/j.prro.2013.02.008

RE-AIMS 09/15/2017


51. Mou B, Beltran CJ, Park SS, Olivier KR, Furutani KM. Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study. PLoS One. 2014; 9: (6)e98621. PMID:24887068 PMCID:4041776 DOI:10.1371/journal.pone.0098621

52. Saito AI, Olivier KR, Li JG, Liu C, Newlin HE, Schmalfuss I, Kyogoku S, Dempsey JF. Lung tumor motion change during stereotactic body radiotherapy (SBRT): An evaluation using MRI. J appl clin med phys. 2014; 15(3):25-31.

53. Owen D, Olivier KR, Song L, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung. Front Oncol. 2014; 4: ()376. PMID:25642416 PMCID:4294121 DOI:10.3389/fonc.2014.00376

54. Brown LC, Lester RA, Grams MP, Haddock MG, Olivier KR, Arndt CA, Rose PS, Laack NN. Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma. Sarcoma. 2014; 2014: ()418270. PMID:25548538 PMCID:4274855 DOI:10.1155/2014/418270

55. * Owen D, Laack NN, Mayo CS, Garces YI, Park SS, Bauer HJ, Nelson K, Miller RW, Brown PD, Olivier KR. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Pract Radiat Oncol. 2014 Mar-Apr; 4: (2)e143-9. PMID:24890360 PMCID:4364394 DOI:10.1016/j.prro.2013.05.006

56. * Frechette KM, Brown LC, Aubry MC, Wigle DA, Olivier KR. Pseudoprogression after stereotactic body radiotherapy. J Thorac Oncol. 2014 Apr; 9(4):e29-30. PMID:24736086 DOI:10.1097/JTO.0000000000000067

57. Welch BT, Callstrom MR, Morris JM, Kurup AN, Schmit GD, Weisbrod AJ, Lohse CM, Kohli M, Costello BA, Olivier KR, Thompson RH, Boorjian SA, Atwell TD. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma. J Urol. 2014 Aug; 192: (2)357-63. PMID:24631107 DOI:10.1016/j.juro.2014.03.006

58. Sio TT, Jensen AR, Miller RC, de Los Santos LE, Hallemeier CL, Foster NR, Park SS, Bauer HJ, Chang K, Garces YI, Olivier KR. Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors. J Appl Clin Med Phys. 2014 Sep; 15: (5)235-245. PMID:28297227 DOI:10.1120/jacmp.v15i5.4931

59. * Sio TT, Jensen AR, Miller RC, Fong de los Santos LE, Hallemeier CL, Foster NR, Park SS, Bauer HJ, Chang K, Garces YI, Olivier KR. Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors. J Appl Clin Med Phys. 2014 Sep 08; 15: (5)4931. PMID:25207580

60. Hegg RM, Kurup AN, Schmit GD, Weisbrod AJ, Atwell TD, Olivier KR, Moynihan TJ, Callstrom MR. Cryoablation of sternal metastases for pain palliation and local tumor control. J Vasc Interv Radiol. 2014 Nov; 25(11):1665-70. Epub 2014 Sep 23. PMID:25255705 DOI:10.1016/j.jvir.2014.08.011

61. * Brown LC, Laack TA, Ma DJ, Olivier KR, Laack NN. Multidisciplinary medical simulation: a novel educational approach to preparing radiation oncology residents for oncologic emergent on-call treatments. Int J Radiat Oncol Biol Phys. 2014 Nov 1; 90(3):705-6. Epub 2014 Sep 26. PMID:25304952 DOI:10.1016/j.ijrobp.2014.06.053

62. Grams MP, Fong de Los Santos LE, Brown LC, Mayo CS, Park SS, Garces YI, Olivier KR, Brinkmann DH. Separating the dosimetric consequences of changing tumor anatomy from positional uncertainty for conventionally fractionated lung cancer patients. Pract Radiat Oncol. 2014 Nov-Dec; 4: (6)455-65. PMID:25407869 DOI:10.1016/j.prro.2014.02.006

63. * Owen D, Olivier KR, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules. Radiat Oncol. 2015; 10: ()43. PMID:25889747 PMCID:4341868 DOI:10.1186/s13014-015-0340-9

RE-AIMS 09/15/2017


64. Park SS, Dong H, Liu X, Harrington SM, Krco CJ, Grams MP, Mansfield AS, Furutani KM, Olivier KR, Kwon ED. PD-1 Restrains Radiotherapy-Induced Abscopal Effect. Cancer Immunol Res. 2015 Jun; 3: (6)610-9. PMID:25701325 PMCID:4827718 DOI:10.1158/2326-6066.CIR-14-0138

65. Spiceland CM, Olivier KR, Jatoi A. Radiation-Refractory Brain Metastases in Patients with Non-Small Cell Lung Cancer. J Palliat Med. 2015 Aug; 18: (8)707-10. PMID:26218580 DOI:10.1089/jpm.2015.0097

66. Stish BJ, Hallemeier CL, Olivier KR, Harmsen WS, Allen MS, Garces YI. Long-Term Outcomes and Patterns of Failure After Surgical Resection of Small-Cell Lung Cancer. Clin Lung Cancer. 2015 Sep; 16: (5)e67-73. PMID:25823413 DOI:10.1016/j.cllc.2015.02.004

67. Blanchard M, Shim KG, Grams MP, Rajani K, Diaz RM, Furutani KM, Thompson J, Olivier KR, Park SS, Markovic SN, Pandha H, Melcher A, Harrington K, Zaidi S, Vile R. Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93: (3)577-87. PMID:26461000 PMCID:4877702 DOI:10.1016/j.ijrobp.2015.07.2274

68. Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Timmerman RD, Choy H. A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys. 2015 Nov 15; 93: (4)757-64. PMID:26530743 PMCID:4744654 DOI:10.1016/j.ijrobp.2015.07.2260

69. Owen D, Mayo CS, Song L, Ahmed K, Laack N, Olivier K. Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy. Adv Radiat Oncol. 2016 Jan-Mar; 1 (1):76-81 Epub 2015 Dec 19 PMID:28799577 PMCID:5506717 DOI:10.1016/j.adro.2015.12.001

70. Ost P, Jereczek-Fossa BA, As NV, Zilli T, Muacevic A, Olivier K, Henderson D, Casamassima F, Orecchia R, Surgo A, Brown L, Tree A, Miralbell R, De Meerleer G. Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis. Eur Urol. 2016 Jan; 69: (1)9-12. PMID:26189689 DOI:10.1016/j.eururo.2015.07.004

71. Grams MP, Fong de Los Santos LE, Antolak JA, Brinkmann DH, Clarke MJ, Park SS, Olivier KR, Whitaker TJ. Cadaveric verification of the Eclipse AAA algorithm for spine SBRT treatments with titanium hardware. Pract Radiat Oncol. 2016 Mar-Apr; 6: (2)131-41. PMID:26723553 DOI:10.1016/j.prro.2015.10.012

72. * Muldermans JL, Romak LB, Kwon ED, Park SS, Olivier KR. Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016 Jun 01; 95: (2)696-702. PMID:27131082 PMCID:5154616 DOI:10.1016/j.ijrobp.2016.01.032

73. Mayo CS, Pisansky TM, Petersen IA, Yan ES, Davis BJ, Stafford SL, Garces YI, Miller RC, Martenson JA, Mutter RW, Choo R, Hallemeier CL, Laack NN, Ma DJ, Olivier KR, Keole SR, Fatyga M, Foote RL, Haddock MG. Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review. Pract Radiat Oncol. 2016 Jul-Aug; 6: (4)e117-26. PMID:26825250 DOI:10.1016/j.prro.2015.11.001

74. Merrell KW, Mou B, Hallemeier CL, Owen DA, Nelson K, Garces YI, Olivier KR. P1.18: Long-Term Clinical Outcomes and Safety Profile for Central Lung SBRT for NSCLC: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct; 11: (10S)S192. PMID:27676504 DOI:10.1016/j.jtho.2016.08.040

75. Parker WP, Davis BJ, Park SS, Olivier K, Choo CR, Nathan MA, Lowe VJ, Welch TJ, Zaid HB, Sobol II, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes JR, Kwon ED. Patterns of Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: Unique Identification of Sites of Recurrence Impacting Clinical Management. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96: (2S)S112. PMID:27675554 DOI:10.1016/j.ijrobp.2016.06.276

RE-AIMS 09/15/2017


76. Evans JD, Davis BJ, Stish BJ, Park SS, Olivier K, Choo CR, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ. Recurrence Patterns of Oligometastatic Disease Detected Using C-11 Choline Positron Emission Tomography/Computed Tomography in Patients With a Rising Prostate-Specific Antigen Level Following Postprostatectomy Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96: (2S)S103. PMID:27675532 DOI:10.1016/j.ijrobp.2016.06.255

77. Haddad MM, Merrell KW, Hallemeier CL, Johnson GB, Mounajjed T, Olivier KR, Fidler JL, Venkatesh SK. Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review. Abdom Radiol (NY). 2016 Oct; 41: (10)2061-77. PMID:27167232 DOI:10.1007/s00261-016-0768-x

78. Breen WG, Merrell KW, Mansfield AS, Wigle DA, Garces YI, Park SS, Olivier KR, Hallemeier CL. Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non-small cell lung cancer. Adv Radiat Oncol. 2017 Jan-Mar; 2: (1)12-18. PMID:28740911 PMCID:5514239 DOI:10.1016/j.adro.2016.12.004

79. Parker WP, Davis BJ, Park SS, Olivier KR, Choo R, Nathan MA, Lowe VJ, Welch TJ, Evans JD, Harmsen WS, Zaid HB, Sobol I, Moreira DM, Haloi R, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes RJ, Kwon ED. Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission TomographyComputed Tomography: A Nomogram for Predicting Extrapelvic Disease. Eur Urol. 2017 Mar; 71: (3)340-348. PMID:27597240 DOI:10.1016/j.eururo.2016.08.055

80. Parker WP, Evans JD, Stish BJ, Park SS, Olivier K, Choo R, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ, Davis BJ. Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography. Int J Radiat Oncol Biol Phys. 2017 Mar 01; 97: (3)526-535. PMID:28126302 PMCID:5308881 DOI:10.1016/j.ijrobp.2016.11.014

81. Youland RS, Packard AT, Blanchard MJ, Arnett AL, Wiseman GA, Kottschade LA, Dronca RS, Markovic SN, Olivier KR, Park SS. 18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma. Adv Radiat Oncol. 2017 Apr-Jun; 2: (2)204-210. PMID:28740933 PMCID:5514257 DOI:10.1016/j.adro.2017.02.003

82. Arnett AL, Packard AT, Mara K, Mansfield AS, Wigle DA, Haddock MG, Park SS, Olivier KR, Garces YI, Merrell KW. FDG-PET parameters as predictors of pathologic response and nodal clearance in patients with stage III non-small cell lung cancer receiving neoadjuvant chemoradiation and surgery. Pract Radiat Oncol. 2017 Apr 19; : (). PMID:28733185 DOI:10.1016/j.prro.2017.04.013

83. Henkle E, Aksamit TR, Barker AF, Curtis JR, Daley CL, Anne Daniels ML, DiMango A, Eden E, Fennelly K, Griffith DE, Johnson M, Knowles MR, Leitman A, Leitman P, Malanga E, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Prieto D, Salathe M, Thomashow B, Tino G, Turino G, Wisclenny S, Winthrop KL. Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry. Chest. 2017 May 05; : (). PMID:28479113 DOI:10.1016/j.chest.2017.04.167

RE-AIMS 09/15/2017


Book Chapters

1. Moore-Higgs GJ, Olivier KR. New advances in radiotherapy for lung cancer. In: Haas ML editor. Contemporary issues in lung cancer: a nursing perspective. 2nd Edition. Sudbury: Jones and Bartlett Publishers; 2010. p. 107-15.

2. Olivier KR, Garces YI. Radiotherapy for the Locally Advanced Non-Small Cell Lung Cancer. In: Schild SE. Thoracic Malignancies: Radiation Medicine Rounds. 1st ed. Vol. 1. New York: demosMedical; 2010. p. 21-38.

3. Olivier K. Academic comment. In: Small W Jr; Williams TR; Donnelly ED editor. Radiation oncology: difficult cases and practical management. New York: Demos Medical; 2013. p. 181-4.

Letters

1. Olivier KR. Radiotherapy for MALT lymphoma. Mayo Clin Proc. 2004 Feb; 79(2):276. PMID:14959927 DOI:

2. Grams MP, Fong de Los Santos LE, Brown LC, Mayo CS, Park SS, Garces YI, Olivier KR, Brinkmann DH. In Reply to Yartsev and Chen. Pract Radiat Oncol 2015 Sep-Oct; 5 (5):e555 PMID:26362711 DOI:10.1016/j.prro.2015.02.004

Abstracts

1. Olivier K, Kottke T, Bateman A, Harrington K, Linardakis E, Ahmed A, Gough M, Riddle D, Peterson T, Simari R, Melcher A, Vile R. Fusing tumor cell vaccines are potent immunogens at least in part through the release of exosome-like vesicles which load dendritic cells with tumor antigen. Mol Ther. 2003 May; 7(5):S276.

2. Mora GR, Olivier KR, Mitchell RF Jr, Cheville JC, Lingle WL, Tindall DJ. The cytoskeleton differentially localizes the early growth response gene-1 (EGR-1) in cancer and benign cells of the prostate. Proceedings American Association for Cancer Research Annual Meeting. 2003 Jul; 44:261.

3. MacDonald OK, Kazemba B, Olivier KR, Brown PD, Miller RC, Fong de Los Santos L, Garces YL. Comparative analysis of coplanar vs. noncoplanar planning approaches in extra-cranial stereotactic radiotherapy (SBRT) of early stage peripheral non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2009; 75(Suppl S):S686-7.

4. Stauder MC, MacDonald OK, Olivier KR, Miller RC, Brown PD, Garces YI. Early pulmonary toxicity of lung stereotactic body radiation therapy (SBRT) delivered as consecutive daily fractions. Int J Radiat Oncol Biol Phys. 2010; 78(Suppl S):S182-3.

5. Woltman NM, Garces Y, Olivier K, Miller R. Incidence of radiation pneumonitis after thoracic intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2010; 78(Suppl S):S738.

6. Smith KB, Byer G, Morris CG, Kirwan JM, Lightsey J, Mendenhall NP, Hoppe BS, Lynch JW, Olivier K. Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy. Int J Radiat Oncol Biol Phys. 2010; 78(Suppl S):S551.

7. Barney BM, Olivier KR, Wilson ZC, Miller RC, Macdonald OK, Brown PD, Foote RL, Markovic SN. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for stage IV melanoma. Int J Radiat Oncol Biol Phys. 2011; 81(S):S687.

8. Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Olivier KR, Laack NN. Clinical outcomes of single and multifractionated SBRT schedules for spinal metastases. Int J Radiat Oncol Biol Phys. 2011; 81(S):S292-3.

RE-AIMS 09/15/2017


9. Stauder MC, Olivier KR, Macdonald OK, Lafata K, Mayo CS, Bauer HJ, Miller RC, Brown PD, Garces YI. Maximum PTV dose predicts for radiation pneumonitis following lung stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2011; 81(S):S614.

10. Barney B, Olivier K, Miller R, Fong de los Santos L, Haddock M. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for non-liver abdominal cavity tumors. American Journal Of Clinical Oncology-cancer Clinical Trials. 2011 Apr; 34(2):196.

11. Khwaja S, Barney B, Olivier K, Miller R, Haddock M. Clinical outcomes using stereotactic body radiation therapy (SBRT) for metastases to retroperitoneal lymph nodes. American Journal Of Clinical Oncology-cancer Clinical Trials. 2011 Apr; 34(2):206.

12. Hallemeier C, Stauder M, Miller R, Garces Y, Foote R, Bauer H, Lafata K, Mayo C, Olivier K. Lung stereotactic body radiotherapy using coplanar versus non-coplanar beam arrangements: a comparison of clinical outcomes. American Journal Of Clinical Oncology-cancer Clinical Trials. 2012 Apr; 35(2):201.

13. Schild SE, Hillman S, Graham D, Vora S, Garces Y, Olivier K, Kugler J, Ross H, Molina J, Adjei A. Long-term survival of patients(pts) treated with high-dose radiotherapy(rt) & concurrent chemotherapy for unresectable non-small cell lung cancer(nsclc). J Thorac Oncol. 2012 Sep; 7(9):S234.

14. Stauder MC, Roden AC, Wigle D, Price KA, Garces YI, Olivier KR. Radiologic tumor regression and correlation with pathologic findings after neoadjuvant therapy for non-small cell lung cancer. J Thorac Oncol. 2012 Sep; 7(9):S226.

15. Sio TT, Jensen AR, Fong de los Santos LE, Park SS, Hallemeier CL, Ma DJ, Bauer HJ, Olivier KR. S-frame versus bodyfix: a comparison of immobilization techniques for upper lung tumors with stereotactic body radiotherapy. J Thorac Oncol. 2012 Sep; 7(9):S265.

16. Hallemeier CL, Garces YI, Neben-Wittich MA, Olivier KR, Garcia JA, Brown PD, Foote RL. Adjuvant hypofractionated intensity modulated radiation therapy (imrt) after resection of regional lymph node (ln) metastases in patients with malignant melanoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012 Nov 1; 84(3):S505-6.

17. Barney BM, Haddock MG, Miller RC, Olivier KR. Clinical outcomes and toxicity using stereotactic body radiation therapy (sbrt) for advanced cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2012 Nov 1; 84(3):S325.

18. Stauder MC, Roden AC, Wigle D, Price KA, Garces YI, Olivier KR. Radiologic tumor regression and correlation with pathologic findings after neoadjuvant therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012 Nov 1; 84(3):S548-9.

19. Ahmed K, Park SS, Kwon ED, Olivier KR. Role of stereotactic body radiation therapy in oligometastatic, hormone refractory prostate cancer. Int J Radiat Oncol Biol Phys. 2012 Nov 1; 84(3):S360.

20. Sio TT, Jensen AR, Fong de los Santos LE, Park SS, Hallemeier CL, Ma DJ, Bauer HJ, Olivier KR. S-frame versus dual vacuum: a comparison of immobilization techniques for upper lung tumors with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Nov 1; 84(3):S726.

21. Mayo C, Zankowski C, Herman M, Miller R, Olivier K, Suominen J. A method to vectorize the dose distribution, the dose volume histogram (Abstract SUâ€Eâ€Tâ€487) Medical Physics. 2013; 40: (6)318.

RE-AIMS 09/15/2017


22. Grams M, Fong de Los Santos L, Brown L, Olivier K, Brinkmann D. Separating the dosimetric consequences of changing tumor anatomy vs. positional uncertainty for conventionally fractionated lung cancer patients (Abstract THâ€Câ€137â€04) Medical Physics. 2013; 40: (6)533.

23. Merrell KW, Barney BM, Yan E, Laack NN, Olivier KR. A comparison of standard fractionation and stereotactic body radiation therapy in the treatment of metastatic breast cancer. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S232-3.

24. Merrell KW, Barney BM, Park SS, Laack NN, Haddock MG, Miller RC, Olivier KR. An institutional review of stereotactic body radiation therapy for liver tumors. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S322-3.

25. Owen D, Mayo C, Ahmed K, Laack N, Olivier K. Cord and thecal sac dosimetric correlation with toxicity for spine sbrt. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S55-6.

26. Owen D, Laack NN, Mayo C, Garces YI, Park S, Bauer HJ, Nelson K, Miller RW, Brown PD, Olivier KR. Outcomes and toxicities of stereotactic body radiation therapy (sbrt) for nonspine osseous oligometastases. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S724.

27. Videtic GM, Hu C, Singh A, Chang JY, Parker W, Olivier K, Schild S, Komaki R, Urbanic J, Choy H. Radiation therapy oncology group (rtog) protocol 0915: a randomized phase 2 study comparing 2 stereotactic body radiation therapy (sbrt) schedules for medically inoperable patients with stage i peripheral non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S3.

28. Brown LC, Lester RA, Haddock MG, Sarkaria JN, Olivier KR, Arndt CAS, Laack NN. Stereotactic body radiation therapy (sbrt) for pediatric bone tumors. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S71.

29. Barney BM, Callstrom MR, Merrell KW, Hardie JG, Olivier KR. Stereotactic body radiation therapy after other minimally-invasive local therapies for liver tumors. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S316.

30. Videtic G, Hu C, Singh A, Chang J, Parker W, Olivier K, Schild S, Komaki R, Urbanic J, Choy H. Radiation therapy oncology group (rtog) protocol 0915: a randomized phase ii study comparing 2 stereotactic body radiation therapy (sbrt) schedules for medically inoperable patients (pts) with stage i peripheral non-small cell lung cancer. J Thorac Oncol. 2013 Nov; 8:S170.

31. Blanchard MJ, Zaidi S, Grams M, Shim K, Rajani K, Diaz R, Furutani K, Olivier K, Park S, Vile R. Definitive management of oligometastatic melanoma in a murine model using combined ablative radiation therapy (sabr) and viroimmunotherapy (vi). Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S57.

32. Merrell KW, Francis SR, Mou B, Hallemeier CL, Olivier KR. Outcomes and prognostic factors of stereotactic body radiation therapy for soft-tissue sarcoma metastases. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S765-6.

33. Park SS, Dong H, Zhao W, Grams MP, Liu X, Harrington SM, Furutani KM, Krco CJ, Olivier KR, Markovic SN, Kwon ED. Pd-1 blockade enhances radiation therapy-induced abscopal effect. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S57-8.

34. Shaffer J, Feng MU, Pollom E, Stenmark MH, Tang M, Monroe AT, Lee P, Merrell KW, Olivier KR, Koong AC, Chang DT. Pooled analysis of liver stereotactic body radiation therapy for colorectal metastases: results from 5 institutions. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S376.

RE-AIMS 09/15/2017


35. Chang DT, Shaffer J, Pollom E, Stenmark MH, Tang M, Merrell KW, Lee P, Olivier KR, Koong AC, Feng MU. Pooled analysis of liver stereotactic body radiation therapy for hepatocellular carcinoma: results from a multi-institution study. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S376.

36. Shaffer J, Feng MU, Pollom E, Stenmark MH, Tang M, Monroe AT, Merrell KW, Lee P, Olivier KR, Koong AC, Chang DT. Pooled analysis of stereotactic body radiation therapy for liver tumors: results from 5 institutions. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S380-1.

37. Owen D, Mayo CS, Song LS, Ahmed K, Laack NN, Olivier KR. Pushing the dose to the spinal cord in spine sbrt - cord and thecal sac dosimetric correlation with toxicity. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S25.

38. Merrell K, Seder C, Mou B, Wilson Z, Hallemeier C, Olivier K, Wigle D, Garces Y. Radiation dose response and clinical outcomes with trimodality therapy for stage iiia non-small cell lung cancer. J Thorac Oncol. 2014 Sep; 9(9):S156-7.

39. Mou B, Merrell KW, Owen DA, Nelson KE, Garces YI, Olivier KR. Stereotactic body radiation therapy for central lung tumors: outcomes and toxicity. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S623.

40. Vu CC, Sio TT, Chang K, Miller RC, Garces YI, Park SS, Nelson KE, Sloan JA, Olivier KR. Baseline patient-reported quality of life is not related to overall survival in patients receiving stereotactic body radiation therapy for thoracic malignancies: a preliminary report. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90:S59.

41. Mou B, Merrell KW, Owen DA, Nelson KE, Garces YI, Olivier KR. Stereotactic body radiation therapy for central lung tumors: outcomes and toxicity. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90:S80.

42. Breen W, Merrell K, Mansfield A, Wigle D, Garces Y, Olivier K, Hallemeier C. Predictors of relapse and evaluation of post-operative radiotherapy in patients with resected stage iii (n2) non-small cell lung cancer Journal Of Thoracic Oncology. 2015 Sep; 10: (9)S574.

43. Youland RS, Blanchard MJ, Markovic SN, Olivier K, Park SS. A comparison of stereotactic body radiation therapy (sbrt) versus conventional/hypofractionated radiation therapy (chrt) for metastatic malignant melanoma (mm) International Journal Of Radiation Oncology Biology Physics. 2015 Nov 1; 93: (3)E629-30.

44. Grams M, Clarke M, Antolak JA, Brinkmann DH, Fong de los Santos L, Mayo C, Park SS, Olivier K, Whitaker TJ. Cadaveric verification of vmat dose distributions for spine sbrt treatments with titanium implants International Journal Of Radiation Oncology Biology Physics. 2015 Nov 1; 93: (3)E547-8.

45. Park SS, Dong H, Harrington S, Grams M, Mansfield AS, Furutani KM, Olivier K, Kwon ED. Cd11a(high)cd8(+) t cell phenotype identifies tumor specific effector cells whose frequency and function are enhanced by rt International Journal Of Radiation Oncology Biology Physics. 2015 Nov 1; 93: (3)S96.

46. Hobbs CJ, Ko S, Paryani NN, Olivier K, Garces Y, Park SS, Hallemeier CL, Schild SE, Vora S, Ashman J, Rule WG, Bowers JR, Heckman MG, Diehl NN, Miller RC. Stereotactic body radiation therapy (sbrt) for early-stage non$132#small cell lung cancer (nsclc) and impact of maximum standardized uptake value (suvmax), biologically effective dose (bed), and mediastinal staging on prognosis International Journal Of Radiation Oncology Biology Physics. 2015 Nov 1; 93: (3)S102.

47. Shiraishi S, Grams MP, Antolak JA, Park SS, Olivier KR, Garces YI, Fong LE. Experimental Verification of Eclipse AAA and Acuros Lung Dose Calculations Journal of Applied Clinical Medical Physics.2017 May 15;18:(3)227. Abstract no.PO-BPC-Exhibit Hall-10.

RE-AIMS 09/15/2017


* Indicates that the primary author was a mentee of this author.


Documents

Curriculum Vitae and Bibliography Kenneth R Olivier, MD · Curriculum Vitae and Bibliography Present Academic Rank and Position Consultant - Department of Radiation Oncology, Mayo